From the Field

Results of the 2002 National Health Interview Survey, establishes data on the prevalence of visual impairment, blindness, and four eye conditions (cataract, diabetic retinopathy, glaucoma, and macular degeneration) in the United States and characterizes these conditions within sociodemographic subgr...

Full description

Saved in:
Bibliographic Details
Published in:Journal of visual impairment & blindness 2008-03, Vol.102 (3), p.177-184
Main Authors: Ryskulova, Asel, Turczyn, Kathleen, Makuc, Diane M, Cotch, Mary Frances, Klein, Richard J, Janiszewski, Rosemary
Format: Article
Language:English
Subjects:
Appointments & personnel changes
Assistive Technology
Blindness
Diabetes
Drugs
Eyes & eyesight
Genetics
Macular degeneration
Narcotics
National Surveys
Ophthalmology
Patients
Periodicals
Public Health
Research and Development
Vision
Visual impairment
Visual Impairments
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Results of the 2002 National Health Interview Survey, establishes data on the prevalence of visual impairment, blindness, and four eye conditions (cataract, diabetic retinopathy, glaucoma, and macular degeneration) in the United States and characterizes these conditions within sociodemographic subgroups, thus providing new baseline data for future public health initiatives relating to visual impairment. DRUGS TO TREAT AGE-RELATED MACULAR DEGENERATION COMPARED IN TRIAL In late February 2008, the National Institutes of Health (NIH) initiated a head-to-head trial of two Genentech drugs designed to treat the wet form of age-related macular degeneration (AMD), which occurs when abnormal blood vessel growth harms or destroys part of the eye.
ISSN:0145-482X
1559-1476
DOI:10.1177/0145482X0810200308